News & Events
-
Public Calendar: May 23-27, 2011
This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.
| May 23-27, 2011 | |||||
| FDA Official and Title | Date | Location | Other FDA Participants | Non-FDA Participants | Subject |
|---|---|---|---|---|---|
| Margaret A. Hamburg, M.D., Commissioner of Food and Drugs | 5/24/11 | Washington, DC | N/A | N/A | Speech at the 2010-2011 Women’s Conservation Forum |
| Margaret A. Hamburg, M.D., Commissioner of Food and Drugs | 5/25/11 | Boston, MA | N/A | N/A | Panel Remarks at One Mind for Research Forum on New Developments in Translational Science: Compounds to Cures |
| Margaret A. Hamburg, M.D., Commissioner of Food and Drugs | 5/26/11 | New York, NY | N/A | N/A | Speech at the Hertog Global Strategy Initiative Lecture Series on Global Infectious Disease Threats and the Role of FDA: Past, Present and Future |
| John M. Taylor, III, J.D., Acting Principal Deputy Commissioner of Food and Drugs | 5/23/11-5/27/11 | N/A | N/A | N/A | No Significant Meetings |
| Dara A. Corrigan, Associate Commissioner for Regulatory Affairs | 5/23/11-5/27/11 | N/A | N/A | N/A | No Significant Meetings |
| Lawrence Deyton, M.S.P.H., M.D., Director, Center for Tobacco Products | 5/26/11 | Washington, DC | Ann Simoneau | Several representatives from the American Heart Association, the American Lung Association, and the American Cancer Society | Webinar hosted by Campaign for Tobacco-Free Kids |
| David Dorsey, J.D., Acting Deputy Commissioner for Policy, Planning, and Budget | 5/23/11-5/27/11 | N/A | N/A | N/A | No Significant Meetings |
| Bernadette Dunham, D.V.M., Ph.D., Director, Center for Veterinary Medicine | 5/26/11 | Rockville, MD | William Flynn, Dave White, Steve Vaughn, Pat McDermott) | Mike Apley (Kansas State University College of Veterinary Medicine) | Veterinary Medicine |
| Jesse Goodman, M.D., M.P.H., Chief Scientist and Deputy Commissioner for Science and Public Health | 5/23/11-5/27/11 | N/A | N/A | N/A | No Significant Meetings |
| Michael M. Landa, Acting Director, Center for Food Safety and Applied Nutrition | 5/23/11-5/27/11 | N/A | N/A | N/A | No Significant Meetings |
| Caroline Lewis, Acting Deputy Commissioner for Administration | 5/23/11-5/27/11 | N/A | N/A | N/A | No Significant Meetings |
| Murray M. Lumpkin, M.D., Deputy Commissioner for International Programs | 5/23/11-5/27/11 | N/A | N/A | N/A | No Significant Meetings |
| Karen Midthun, M.D., Director, Center for Biologics Evaluation and Research | 5/23/11-5/27/11 | N/A | N/A | N/A | No Significant Meetings |
| Meghan Scott, Acting Associate Commissioner for External Affairs | 5/23/11 | Teleconference | Julie Zawisza | Peter Pitts (Center for Medicine in the Public Interest) | Social Media Guidance for Industry |
| Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health | 5/24/11 | Silver Spring, MD | Jonathan Sackner, Alberto Gutierrez, William Maisel, Rachel Turow, Barbara Zimmerman | Jill Olmstead, Chris Wasden, Albert Malvehy (Pricewaterhouse- Coopers) | Medical Devices |
| William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research | 5/23/11-5/27/11 | N/A | N/A | N/A | No Significant Meetings |
| Michael R. Taylor, J.D., Deputy Commissioner for Foods, Office of Foods | 5/23/11-5/27/11 | N/A | N/A | N/A | No Significant Meetings |
| Ralph Tyler, J.D., Chief Counsel | 5/23/11-5/27/11 | N/A | N/A | N/A | No Significant Meetings |
| Jill Hartzler Warner, J.D., Acting Associate Commissioner for Special Medical Programs | 5/23/11-5/27/11 | N/A | N/A | N/A | No Significant Meetings |
| Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research | 5/22/11-5/24/11 | Sausalito, CA | Robert Becker | Donald Berry (The University of Texas MD Anderson Cancer Center); Laura Esserman (University of California San Francisco Medical Center); Anna Barker (Quantum Leap Foundation) | Accelerating Targeted Cancer Drug-Biomarker Development through Innovative Pre-Competitive Collaborations and Clinical Trial Processes |
-
-
